Subscribe

The Best Tech and Biotech Stocks

 

We scan the entire market for tech and biotech ideas and we add the best to our Orders queue, while we wait for an optimal entry point. Once those companies reach our price targets, we add them to our real-time Portfolio.  New trades are accompanied by an audible chime and blue highlighting.

 

The areas we cover include:

Biotechnology

  • Genomics and Synthetic Biology
  • Gene Editing
  • Cancer Therapeutics and Diagnostics
  • Regenerative Medicine
  • Pharmaceuticals
  • Reproductive Medicine

 

 

Technology

  • AI and Supercomputing
  • Robotics and Autonomous Vehicles
  • Virtual and Augmented Reality
  • Solar Energy
  • Nanotech, 3D Printing, and Material Science
  • Space and Aerospace

 

 

No Hype. No Long Stories.

 

Anyone who believes in the concepts of exponential technological change respects that time increases in value every day. We will NOT waste your time with long monthly essays hyping our latest stock pick. We also won’t pretend that we’ve uncovered secret knowledge that is not readily found in the public domain.

 

You will NOT read “this obscure biotech is about to make investors millions (for those who act now) with their latest breakthrough discovery!” from us. We read these headlines from our competitors and laugh because 1) many are truly just “stories” and 2) the few good ones are already in our Portfolio and watch list.

 

What we do offer is your TIME back — and a break from the hype and extravagant claims. What we do offer are brief comments for each of our Portfolio positions. For our subscribers that enjoy learning the deeper back-stories to our picks, we provide links to our favorite outside experts and writers, so you can read as much or as little as you wish.

 

Fundamental and Technical Analysis

 

What truly separates our service from the pack is our focus on technical analysis. While fundamentals are the basis for our initial interest, technicals are the basis for our buying and selling decisions. Developed and refined over years, our proprietary technical methods let us know when we can buy with maximum safety or sell after taking maximum gains. We won’t talk much about it, as our methods are unique and  proprietary, but we’ll let our performance speak for itself…

 

Performance Tracking

 

How many newsletters tout their biggest winners but do NOT disclose their total portfolio performance, including their losers? Answer: nearly all. If their total performance is good, why do they omit it from their marketing? While that kind of spin may get them greater sales, we feel it is dishonest.

 

Low Cost

 

Comparable services charge from $2000-$5000 annually. We charge half of the low end at $999 per year or $99 per month.

 

How We Compare

 

DNA Investor Competitors
Tech and Biotech
Time Efficient
Fundamental Analysis
Technical Analysis
Performance Tracking
Cost $999 $2000-$5000

Subscribe

[easy-pricing-table id=”1798″]